| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 358 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 828 | 0 | 0 | 0 | 358 | 120.273 | 0 | 0 |
| Total Expenses - EUR | 473 | 446 | 915 | 97 | 5 | 10 | 1.456 | 7.006 | 414 | 109 |
| Gross Profit/Loss - EUR | -473 | -446 | -88 | -97 | -5 | -10 | -1.099 | 113.267 | -414 | -109 |
| Net Profit/Loss - EUR | -473 | -446 | -112 | -97 | -5 | -10 | -1.110 | 109.659 | -414 | -109 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Floramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.850 | 5.466 | 5.373 | 5.241 | 5.140 | 5.042 | 4.909 | 0 | 0 | 0 |
| Current Assets | 2.871 | 55 | 225 | 145 | 138 | 133 | 102 | 111.558 | 1.453 | 1.376 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.851 | 60 | 165 | 86 | 81 | 78 | 63 | 109.686 | 1.459 | 1.387 |
| Cash | 20 | -5 | 60 | 59 | 57 | 55 | 39 | 1.872 | 0 | -11 |
| Shareholders Funds | 7.852 | 4.653 | 4.462 | 4.283 | 4.195 | 4.105 | 2.905 | 111.558 | 1.453 | 1.336 |
| Social Capital | 180 | 178 | 175 | 172 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 869 | 868 | 1.136 | 1.103 | 1.082 | 1.069 | 2.106 | 0 | 0 | 40 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Floramed Srl